Greenberg Traurig Advises APx Acquisition Corp. I in Business Combination Agreement to Create AI-Driven Genomics Company
Global law firm Greenberg Traurig, P.A. advised APx Acquisition Corp. I, a special purpose acquisition company, in its definitive business combination agreement with OmnigenicsAI Corp, a precision medicine company incubated by Bioceres Group PLC, and MultiplAI Health Ltd, a UK-based AI-enabled preventive medicine company. The strategic combination will create a global AI-driven genomics company with a significant […]

Navigation